COVID-19 Emergency

This section gathers the most relevant and updated information on ongoing trials, on medicines used outside clinical trials, on observational studies related to COVID-19 and on correct use of medicines in the population exposed to the virus.

Site Map

Informazione continua sui farmaci

PDF Ongoing information on medicinal products [0.1 Mb] >

Useful links

Ministry of Health - Novel Coronavirus

National Institute of Health - Novel Coronavirus

Questions and answers on labelling flexibilities for COVID-19 vaccines

Indicazioni ad interim sulle misure di prevenzione e controllo delle infezioni da SARS-CoV-2 in tema di varianti e vaccinazione anti-COVID-19

AIFA communications about COVID-19 emergency

10/09/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventitreesimo report

10/09/2021

Eighth AIFA Report on the surveillance of COVID-19 vaccines

10/09/2021

Prevention of SARS-CoV-2 (COVID-19) infections: requests for the import of unauthorized medicines used in place of authorized vaccines

09/09/2021

AIFA’s Scientific Technical Committee issues opinion on administering additional doses of COVID-19 vaccines

09/09/2021

Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer

06/09/2021

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

03/09/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventiduesimo report

02/09/2021

ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines

27/08/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventunesimo report

25/08/2021

After serious adverse reactions affecting coagulation with first dose Vaxzevria possible booster with m-RNA vaccine even in over 60s

24/08/2021

Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna

20/08/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventesimo report

20/08/2021

AIFA denies fake news: authorisations for anti-COVID vaccines remain valid

16/08/2021

EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19

13/08/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il diciannovesimo report

10/08/2021

Modifiche Registro - anticorpi monoclonali COVID-19

06/08/2021

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il diciottesimo report

05/08/2021

Definition of optimal use of anti COVID-19 monoclonal antibodies

04/08/2021

ECDC and EMA update on COVID-19

04/08/2021

Seventh AIFA Report on the surveillance of COVID-19 vaccines

All news

— 20 Items per Page

Showing 1 - 20 of 293 results.

Site Map